These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21034357)

  • 1. DCPIP (2,6-dichlorophenolindophenol) as a genotype-directed redox chemotherapeutic targeting NQO1*2 breast carcinoma.
    Cabello CM; Lamore SD; Bair WB; Davis AL; Azimian SM; Wondrak GT
    Free Radic Res; 2011 Mar; 45(3):276-92. PubMed ID: 21034357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimelanoma activity of the redox dye DCPIP (2,6-dichlorophenolindophenol) is antagonized by NQO1.
    Cabello CM; Bair WB; Bause AS; Wondrak GT
    Biochem Pharmacol; 2009 Aug; 78(4):344-54. PubMed ID: 19394313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer.
    Fagerholm R; Hofstetter B; Tommiska J; Aaltonen K; Vrtel R; Syrjäkoski K; Kallioniemi A; Kilpivaara O; Mannermaa A; Kosma VM; Uusitupa M; Eskelinen M; Kataja V; Aittomäki K; von Smitten K; Heikkilä P; Lukas J; Holli K; Bartkova J; Blomqvist C; Bartek J; Nevanlinna H
    Nat Genet; 2008 Jul; 40(7):844-53. PubMed ID: 18511948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The quinone methide aurin is a heat shock response inducer that causes proteotoxic stress and Noxa-dependent apoptosis in malignant melanoma cells.
    Davis AL; Qiao S; Lesson JL; Rojo de la Vega M; Park SL; Seanez CM; Gokhale V; Cabello CM; Wondrak GT
    J Biol Chem; 2015 Jan; 290(3):1623-38. PubMed ID: 25477506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of NAD(P)H:quinone oxidoreductase 1 (NQO1) and genomic gain of the NQO1 locus modulates breast cancer cell sensitivity to quinones.
    Glorieux C; Sandoval JM; Dejeans N; Ameye G; Poirel HA; Verrax J; Calderon PB
    Life Sci; 2016 Jan; 145():57-65. PubMed ID: 26687450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NAD(P)H:quinone oxidoreductase 1 Arg139Trp and Pro187Ser polymorphisms imbalance estrogen metabolism towards DNA adduct formation in human mammary epithelial cells.
    Singh S; Zahid M; Saeed M; Gaikwad NW; Meza JL; Cavalieri EL; Rogan EG; Chakravarti D
    J Steroid Biochem Mol Biol; 2009 Oct; 117(1-3):56-66. PubMed ID: 19628038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing the Electron Transfer Reactant Phenazine Methosulfate (PMS) for the Apoptotic Elimination of Malignant Melanoma Cells through Induction of Lethal Oxidative and Mitochondriotoxic Stress.
    Hua AB; Justiniano R; Perer J; Park SL; Li H; Cabello CM; Wondrak GT
    Cancers (Basel); 2019 Apr; 11(5):. PubMed ID: 31035569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin stabilizes p53 by interaction with NAD(P)H:quinone oxidoreductase 1 in tumor-derived cell lines.
    Patiño-Morales CC; Soto-Reyes E; Arechaga-Ocampo E; Ortiz-Sánchez E; Antonio-Véjar V; Pedraza-Chaverri J; García-Carrancá A
    Redox Biol; 2020 Jan; 28():101320. PubMed ID: 31526948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct responses of compartmentalized glutathione redox potentials to pharmacologic quinones targeting NQO1.
    Kolossov VL; Ponnuraj N; Beaudoin JN; Leslie MT; Kenis PJ; Gaskins HR
    Biochem Biophys Res Commun; 2017 Jan; 483(1):680-686. PubMed ID: 27986568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C609T polymorphism of NAD(P)H quinone oxidoreductase 1 as a predictive biomarker for response to amrubicin.
    Takakuwa O; Oguri T; Ozasa H; Uemura T; Kunii E; Kasai D; Miyazaki M; Maeno K; Sato S
    J Thorac Oncol; 2011 Nov; 6(11):1826-32. PubMed ID: 21964527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of NAD(P)H-quinone oxidoreductase 1 enhanced the susceptibility of cholangiocarcinoma cells to chemotherapeutic agents.
    Zeekpudsa P; Kukongviriyapan V; Senggunprai L; Sripa B; Prawan A
    J Exp Clin Cancer Res; 2014 Jan; 33(1):11. PubMed ID: 24460787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NQO1-activated phenothiazinium redox cyclers for the targeted bioreductive induction of cancer cell apoptosis.
    Wondrak GT
    Free Radic Biol Med; 2007 Jul; 43(2):178-90. PubMed ID: 17603928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAD(P)H:quinone oxidoreductase 1 Pro187Ser polymorphism and expression do not cosegregate with clinico-pathological characteristics of human mammary tumors.
    Hubackova M; Vaclavikova R; Mrhalova M; Kubackova K; Kodet R; Gut I; Soucek P
    Pharmacogenet Genomics; 2009 Jul; 19(7):505-12. PubMed ID: 19494791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a new isogenic cell-xenograft system for evaluation of NAD(P)H:quinone oxidoreductase-directed antitumor quinones: evaluation of the activity of RH1.
    Dehn DL; Winski SL; Ross D
    Clin Cancer Res; 2004 May; 10(9):3147-55. PubMed ID: 15131056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiostrepton is an inducer of oxidative and proteotoxic stress that impairs viability of human melanoma cells but not primary melanocytes.
    Qiao S; Lamore SD; Cabello CM; Lesson JL; Muñoz-Rodriguez JL; Wondrak GT
    Biochem Pharmacol; 2012 May; 83(9):1229-40. PubMed ID: 22321511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NQO1 expression correlates inversely with NFκB activation in human breast cancer.
    Jamshidi M; Bartkova J; Greco D; Tommiska J; Fagerholm R; Aittomäki K; Mattson J; Villman K; Vrtel R; Lukas J; Heikkilä P; Blomqvist C; Bartek J; Nevanlinna H
    Breast Cancer Res Treat; 2012 Apr; 132(3):955-68. PubMed ID: 21706157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic silencing of NAD(P)H:quinone oxidoreductase 1 by hepatitis B virus X protein increases mitochondrial injury and cellular susceptibility to oxidative stress in hepatoma cells.
    Wu YL; Wang D; Peng XE; Chen YL; Zheng DL; Chen WN; Lin X
    Free Radic Biol Med; 2013 Dec; 65():632-644. PubMed ID: 23920313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase).
    Traver RD; Siegel D; Beall HD; Phillips RM; Gibson NW; Franklin WA; Ross D
    Br J Cancer; 1997; 75(1):69-75. PubMed ID: 9000600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory cytokines suppress NAD(P)H:quinone oxidoreductase-1 and induce oxidative stress in cholangiocarcinoma cells.
    Prawan A; Buranrat B; Kukongviriyapan U; Sripa B; Kukongviriyapan V
    J Cancer Res Clin Oncol; 2009 Apr; 135(4):515-22. PubMed ID: 18820947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implication of alternative splicing for expression of a variant NAD(P)H:quinone oxidoreductase-1 with a single nucleotide polymorphism at 465C>T.
    Pan SS; Han Y; Farabaugh P; Xia H
    Pharmacogenetics; 2002 Aug; 12(6):479-88. PubMed ID: 12172217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.